In May, Qidu Pharma consecutively passed multiple inspections organized by national and provincial drug regulatory departments. The inspections covered routine supervision, license expansion, GMP compliance assessments, and product registration reviews.

From May 12 to 16, experts dispatched by the Shandong Center for Food and Drug Inspection conducted inspections focusing on: Routine supervision of large-volume injections, small-volume injections, tablets, and products under the 10th centralized procurement program. GMP compliance assessment for oral solutions produced on Line 11C in Workshop 305 and Line 6D in Workshop 402. License expansion assessment for oral solutions on Line 6D in Workshop 402.

During May 22-24, Shandong Center for Food and Drug Inspection performed registration inspections for Concentrated Sodium Chloride Injection regarding new production site addition and production resumption.

From May 22 to 25, experts from National Center for Food and Drug Inspection conducted registration inspections for Qingjin Huatan Granules—the company’s first classical formula product. This marked Qidu Pharma’s first direct inspection by NMPA since the implementation of the 2019 revised Drug Administration Law.

Between May 26 and 29, Shandong Center for Food and Drug Inspection carried out pre-approval on-site registration inspections for Glucose Injection supplemental applications.

Throughout the month, 16 national and provincial experts conducted 13 cumulative inspection days across three phases, covering 9 production workshops. This rigorous process served as a practical assessment of Qidu Pharma’s quality management system and inspection readiness capabilities. All departments involved successfully passed the inspections through coordinated collaboration, systematic preparation, and openness to expert feedback. This demonstrates the effective operation of our quality management system and our workforce’s exceptional professionalism.These successful outcomes reinforce the foundation for sustained quality enhancement and high-quality enterprise development.